Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 1"
topic_facet:"Recruitment Status: Terminated"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Terminated%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Terminated%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Terminated%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject
PubPharm (3.050)
1
Fasting Study of Olanzapine Tablets 20 mg and Zyprexa® Tablets 20 mg : Single-Dose Fasting In Vivo Bioequivalence Study of Olanzapine Tablets (20 mg; Mylan) and Zyprexa® Tablets (20 mg; Eli Lilly) in Healthy Volunteers
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr : Investigational Study of the Effect of Clinical Procedures on Drug Delivery of the Fentanyl Transdermal System (25 µg/hr; Mylan) and Duragesic® (25 µg/hr; Janssen) in Healthy Volunteers
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Dose-escalating Trial With UniCAR02-T Cells and PSMA Target Module (TMpPSMA) in Patients With Progressive Disease After Standard Systemic Therapy in Cancers With Positive PSMA Marker : Multicenter, Open-label, Adaptive Design Phase I Trial With Genetically Modified T-cells Carrying Universal Chimeric Antigen Receptors (UniCAR02-T) in Combination With PSMA Peptide Target Module (TMpPSMA) for the Treatment of Patients With Progressive Disease After Standard Systemic Therapy in Cancers With Positive PSMA Marker
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Combination of Fedratinib and Decitabine for Myeloproliferative Neoplasms (MPN)- Accelerated Phase (AP)/Blast Phase (BP) : Phase I Trial of Fedratinib in Combination With Decitabine in Patients With Myeloproliferative Neoplasms in Accelerated and Blast Phase
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
A Study of PF-07260437 in Advanced or Metastatic Solid Tumors : A PHASE 1 DOSE ESCALATION AND EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETIC, PHARMACODYNAMIC, AND ANTITUMOR ACTIVITY OF PF-07260437 IN ADVANCED OR METASTATIC SOLID TUMORS
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Immunologic Response to Kansui in Treated HIV+ Individuals: a Dose Escalation Study : Immunologic Response to Euphorbia Kansui Extract Powder Prepared as Tea in HIV-infected Antiretroviral Therapy (ART)-Suppressed Individuals: a Dose Escalation Study
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas : A Phase 1, Open-label, Dose Finding Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CC-90011 in Subjects With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc) : A Randomized, Double-Blind, Placebo-Controlled, Repeat-Dose, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics, and Explore Efficacy of TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions : Metformin Chemoprevention of Oral Premalignant Lesions
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss : A Phase 1 Study of AG-270 in the Treatment of Subjects With Advanced Solid Tumors or Lymphoma With Homozygous Deletion of MTAP
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[305]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Phase: Phase 1
Filter aufheben
Thema: Recruitment Status: Terminated
Medienart
3.050
Aufsätze
3.050
E-Artikel
3.050
E-Ressourcen
Zeitschriftentitel
2.994
ClinicalTrials.gov
56
WHO International Clinical Trials Registry Plat...
Thema
3.050
610
Phase: Phase 1
Recruitment Status: Terminated
3.050
Study Type: Interventional
314
Neoplasms
207
Leukemia
159
Lymphoma
142
Carcinoma, Non-Small-Cell Lung
132
Carcinoma
129
Lung Neoplasms
124
Leukemia, Myeloid
120
Medical Condition: Healthy
118
Breast Neoplasms
113
Leukemia, Myeloid, Acute
91
Multiple Myeloma
71
Neoplasms, Plasma Cell
69
Lymphoma, Non-Hodgkin
69
Melanoma
69
Myelodysplastic Syndromes
68
Syndrome
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1.377
2020-
1.588
2010-2019
85
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
3.050
Englisch
Haven't found what you're looking for?
Wird geladen...